MAPK3 and myalgic encephalomeyelitis/chronic fatigue syndrome: Although telmisartan reduced the production of collagen I and collagen III induced by PRR overexpression in CFs, it had no significant effect on the production of TGF-β or the phosphorylation of ERK1/2-MAPK.